Background-Recent work has suggested that the formation of platelet-neutrophil complexes (PNCs) aggravates the severity of inflammatory tissue injury. Given the importance of vasodilator-stimulated phosphoprotein (VASP) for platelet function, we pursued the role of VASP on the formation of PNCs and its impact on the extent of myocardial ischemia-reperfusion (IR) injury. Methods and Results-In initial in vitro studies we found that neutrophils facilitated the movement of platelets across endothelial monolayers. Phosphorylation of VASP reduced the formation of PNCs and transendothelial movement of PNCs. During myocardial IR injury, VASP Ϫ/Ϫ animals demonstrated reduced intravascular formation of PNCs and reduced presence of PNCs within the ischemic myocardial tissue. This was associated with reduced IR injury. Studies using platelet transfer and bone marrow chimeric animals showed that hematopoietic VASP expression was crucial for the intravascular formation of PNCs the presence of PNCs within ischemic myocardial tissue and the extent of myocardial IR injury. Furthermore, phosphorylation of VASP on Ser 153 or Ser 235 reduced intravascular PNC formation and presence of PNCs within ischemic myocardial tissue. This finding was associated with reduced myocardial IR injury. Conclusion-Previously unappreciated, the phosphorylation of VASP performs a key function for the formation of PNCs that is crucially important for the extent of myocardial IR injury. (Circulation. 2011;123:2579-2590.)
A pproximately 3.8 million men and 3.4 million women die of myocardial ischemia-reperfusion (IR) injury each year. 1 In order to minimize the consequences of coronary vessel occlusion, early reperfusion of the infarcted myocardium is the most effective therapy. This approach reduces the size of a myocardial infarction and improves the clinical outcome. Nevertheless, reperfusion of the ischemic myocardium can induce injury. This phenomenon, termed myocardial ischemia-reperfusion injury, paradoxically reduces the beneficial effects of reperfusion. The reperfusion phase is marked by cellular swelling, contracture of myofibrils, and a disruption of the sarcolemma. 2 This structural derangement is caused in part by neutrophils, which are attracted into the ischemic tissue. [3] [4] [5] Platelets also participate in the process of neutrophil recruitment and aggravate myocardial tissue dam-age during the reperfusion phase. 6, 7 Finally, these events result in an inflammatory response, which has significant impact on apoptotic events within the myocardium. 8 
Clinical Perspective on p 2590
Recent work has demonstrated that the formation of platelet-neutrophil complexes (PNCs) significantly affects the extent of inflammatory tissue damage. 9, 10 In a study by Zarbock et al, the extent of acute lung injury was significantly reduced by blocking the formation of PNCs. 9 Furthermore, Weismueller et al demonstrated that neutrophils facilitate transepithelial movement of platelets into the intestinal lumen. 10 Firm adhesion between neutrophils and platelets is achieved by fibrinogen binding to CD11b/CD18 on neutrophils and the glycoprotein (GP) IIb/IIIa receptor on plate-lets. 11 Dynamic changes of the cytoskeleton alter the expression of GP IIb/IIIa on platelets and of CD11b/CD18 on neutrophils. 12 Bennett et al demonstrated that the cytoskeleton determines the affinity of the GP IIb/IIIa receptor to fibrinogen. 13 A key regulatory protein for rapid dynamic changes of the cytoskeleton is vasodilator-stimulated phosphoprotein (VASP). 14 VASP can be phosphorylated on Ser 157 (murine Ser 153 ) in a cAMP and on Ser 239 (murine Ser 235 ) in a cGMP-dependent fashion. The phosphorylation of VASP results in conformal changes of the cellular surface, and is an important component of inhibitory pathways. [15] [16] [17] [18] Vasodilator-stimulated phosphoprotein phosphorylation also influences the presence of the CD11b receptor on neutrophils and of GP IIb/IIIa on platelets. 12, 19, 20 Screening for VASP phosphorylation is used clinically as efficiency control for aggregation inhibitors (clopidogrel) and is known as the platelet reactivity index. 21, 22 Given the importance of PNCs for the extent of inflammatory organ injury and the fact that VASP might affect the formation of PNCs, we pursued the role of VASP on the formation of PNCs and the functional impact of this during myocardial IR injury. As directed by in vitro data demonstrating a significant role of VASP for PNC formation, we found a significant reduction of intravascular PNC formation and reduced presence of PNCs within ischemic myocardium in VASP Ϫ/Ϫ mice. Using bone marrow chimeric animals, we were able to identify that phosphorylation of hematopoietic VASP is an important determinant of PNC formation and for this reason affects the degree of myocardial IR injury.
Methods

Mice
All animal protocols were in accordance with the German guidelines for use of living animals and were approved by the Institutional Animal Care and Use Committee of the Tü bingen University Hospital and the Regierungspräsidium Tü bingen. Vasodilatorstimulated phosphoprotein-deficient mice were generated, validated, and characterized as described previously. 23 The wild-type (WT) controls (C57BL/6J mice) were bred as littermates of VASP Ϫ/Ϫ mice and selected to be similar in age, gender, and weight.
Murine Model of Myocardial Ischemia
After anesthesia was induced, animals were placed on a temperaturecontrolled and heated table to maintain body temperature at 37°C. Animals were orally intubated and ventilated (Servo 900C, Siemens, Germany). After left parasternal thoracotomy, the left coronary artery was visually identified and an 8.0 nylon suture (Prolene, Ethicon, Norderstedt, Germany) was placed around the vessel. Ischemia was induced using a model described previously. 24 Infarct sizes were determined by calculating the percentage of myocardial infarction compared to the area at risk (AAR) using double staining technique with Evan blue and triphenyltetrazolium chloride. 25 Area at risk and the infarct size were determined via planimetry using National Institutes of Health software Image 1.0, and the degree of myocardial damage was calculated as a percentage of infarcted myocardium from the AAR.
Pharmacological Compounds Used
Prostaglandin E 1 (PGE 1 ) (0.14 g ⅐ kg Ϫ1 ⅐ h Ϫ1 , Sigma-Aldrich, Munich, Germany), atrial natriuretic peptide (ANP) (0.04 g ⅐ kg Ϫ1 ⅐ h Ϫ1 , Sigma-Aldrich) or vehicle (0.9% NaCl) was administered by intra-arterial infusion beginning 5 minutes before reperfusion.
In Vivo Small Interfering RNA Repression
To achieve in vivo repression of VASP, we used 2.2 g/g body weight VASP ON-TARGETplus SMARTpool Mouse small interfering RNA (siRNA) dissolved in 5% Glucose-solution. As control, nontargeting siRNA (Thermo Scientific, Lafayette, CO), with at least 4 mismatches to any human, murine, or rat gene, was used. The siRNA target sequences of the VASP pool were J-046659 to 17 with target sequence UGC CAU UGC UGG AGC CAA A, J-046659 to 18 with target sequence AGG AAA UCA UCG AAG UCU U, J-046659 to 19 with target sequence GGG CUA CUG UGA UGC UUU A, J-046659 to 20 with target sequence GAG CUG AGG AAG CGG GGU U.
In Vivo Depletion of Murine Neutrophils and Platelets
We achieved neutrophil depletion using neutrophil-specific antibody treatment (RB6-8C5, 150 g per mouse, intraperitoneally; BD Bioscience) 24 hours before the experiments. We achieved platelet depletion using an antibody-to-mouse thrombocyte serum (50 l per mouse, intravenously; Accurate Chemical and Scientific) 2 hours before the experiments.
Platelet Crossover Injection
Platelets were separated as described previously. 10 Platelets were counted and 1 200 000 platelets per mouse were injected into the carotid artery at the start of the surgical procedure (300 L volume). Before injection platelets were tested through incubation with luciferase (Chronolume) to detect activation.
Isolation of Human Neutrophils and Transendothelial Migration Assay
Peripheral blood was taken from healthy donors into a Sarstedt Monevette containing sodium citrate (Sarstedt, Nümbrecht). Neutrophils were isolated as described previously. 26 Platelet isolation from anticoagulated blood was performed as described previously. 10 Migration assays were performed in the absence or presence of platelets. Briefly, 5ϫ10 5 neutrophils were added together with 2.5ϫ10 7 platelets to the upper chamber of transwell inserts (Costar, Germany) in which human microvascular endothelial cell monolayers were seeded on the apical aspect. A chemotactic gradient was established by adding 1 mol/L phorbol 12-myristate 13-acetate (PMA) to the lower chambers. Transmigration studies were performed in the presence of CD11b antibody (Pharmingen, Heidelberg, Germany) or GP IIb/IIIa antagonist ReoPro. In a subset of experiments, neutrophils and platelets were preincubated with PGE 1 or ANP to study the impact of VASP phosphorylation on translocation. The number of neutrophils in the lower compartment was determined by quantification of the enzymatic activity of the azurophilic neutrophil granule protein myeloperoxidase, sampling 50 L of the basal compartment. The generation of a standard curve by serial dilution of neutrophils was used to evaluate the cell number in the basolateral compartment. In a subset of experiments, staining of cells in the basolateral compartment was performed using Pappenheim stain according to standard protocol.
Flow Cytometry
Briefly, a single-cell suspension of 1ϫ10 5 neutrophils or platelets in 100 L of PBS was incubated with saturating concentrations of indicated primary antibodies for 20 minutes. After 3 washes, the cells were centrifuged at 200g for 5 minutes and resuspended in Cellfix. Fluorescence was evaluated on a FACS Calibur after stimulation with PMA, and data were analyzed by using Cell Quest software (all BD Biosciences, Germany). Antibodies used were CD41a, GP IIb/IIIa epitope PAC-1 (both BD Biosciences), anti-CD18 and anti-CD11b (both BD Bioscience, Germany). In a subset of experiments, neutrophils and platelets were preincubated with PGE 1 or ANP to study the impact of VASP phosphorylation.
For murine flow cytometry, blood was gently collected by cardiac puncture and was immediately anticoagulated. Citrated whole blood samples were incubated with anti-CD42b-PE antibody (Ab) (EMFRET Analytics, Germany) and optionally anti-CD15-FITC Ab (EMFRET Analytics) or anti-CD45-FITC Ab (BD Biosciences) or anti-CD62P-FITC Ab (SantaCruz, Biotechnology, CA). After 30 minutes incubation at 37°C, samples were fixed using CellFix (BD Biosciences). Flow cytometric analysis was performed on a FACScan cytometer (BD Biosciences) as described previously. 27 Platelet-neutrophil aggregates were detected according to the fluorescence of the anti-CD15-FITC Ab and anti-CD45-FITC Ab. In all experiments, suitable isotype controls were used to adjust for nonspecific antibody binding.
Western Blots for VASP and VASP Phosphorylation
Thrombocytes were stimulated with either 10 M ANP or 10 M PGE 1 and lysed. After spinning at 14 000 g for 10 minutes to remove cell debris, the pellet was resuspended in RIPA buffer, and protein concentration was measured. Primary antibodies were for VASP (Cell Signaling, distributed by New England Biolabs, Frankfurt am Main, Germany), pVASP 157 (Cell Signaling), and pVASP 239 (Cell Signaling). Loading conditions were controlled by staining human ␤-actin using a murine monoclonal antibody (Cell Signaling). Murine Western blot analysis was performed as described above.
Immunohistochemistry of Neutrophils and Platelets in Murine Tissue
Immunohistochemical staining was performed with Vectastain ABC Kit (Linaris, Wertheim, Germany). After inhibiting the nonspecific binding sites with Avidin blocking solution (Vector, Burlingame, CA), the sections were incubated with primary antibody (rabbit antimouse CD41, Abcam) overnight at 4°C. Tissue sections were then incubated with biotinylated anti rabbit immunoglobulin for 1 hour followed by Vectastain ABC Reagent for 30 minutes, and then developed using DAB substrate. For neutrophil staining, the procedure was repeated using rat antimouse neutrophil antibody (AbD Serotec, Düsseldorf, Germany) and histogreen as substrate (Linaris). Counterstaining was performed using nuclear fast red (Linaris). Histological sections were evaluated for the presence of PNCs by manual count within 3 independent tissue sections of each animal.
Generation of Bone Marrow Chimeras
In short, male donor mice (8 to 10 weeks old, 20 to 25 g) were euthanized, marrow harvested by flushing the marrow cavity and bone marrow cells were then centrifuged at 400 g for 5 minutes, resuspended and counted. Recipient mice (8 to 10 weeks of age, 20 to 25 g) were irradiated with a total dose of 12 Gy from a 137Cs source. Immediately after irradiation, 10 7 BM cells/recipient were injected in 150 l 0.9% sodium chloride into the tail vein. The resulting chimeric mice were housed in microisolators for at least 8 weeks before experimentation and fed with water containing tetracycline (100 mg/L) in the first 2 weeks after bone marrow transplantation. Bone marrow cells were transplanted to generate (1) 
Troponin I Measurement
Blood was collected by central venous puncture for troponin I measurements using a quantitative rapid troponin I assay (Life Diagnostics Inc, West Chester, PA).
Data Analysis
All values are expressed as meanϮSEM. Using the Kolmogorov-Smirnov test, we could show that the measured values were approximately normally distributed. Statistical significance was determined using 1-way ANOVA followed by the Bonferroni multiplecomparison test. Student t test was used where appropriate. A value of PϽ0.05 was considered significant.
Results
Vasodilator-Stimulated Phosphoprotein Phosphorylation Affects Neutrophil Facilitated Transendothelial Platelet Movement
The importance of PNC formation for inflammatory tissue injury was reported previously. 9, 10 In an initial experiment, we performed transendothelial movement studies to transfer previous findings reported in an epithelial cell model. 10 Using a chemotactic gradient across an endothelial monolayer we found that neutrophils readily migrate across endothelial monolayers in response to phorbol 12-mystrate 13acetate (PMA) stimulation (online-only Data Supplement Figure I ). When exposing neutrophils and platelets in combination to this experiment, we found a robust increase of cell number and of ATP content within the basolateral compartment ( Figure 1A and 1B and online-only Data Supplement Figure  II ). We then preincubated neutrophils and platelets with a CD11b antibody or the GP IIb/IIIa antagonist ReoPro before conducting transendothelial movement studies. This resulted in a significant decrease of cell number and ATP content in the basolateral compartment ( Figure 1A and 1B) .
Previous work has suggested that actin dynamics might influence the exposure of CD11b/CD18 or GP IIb/IIIa on the cellular surface. 19, 28 A crucial regulator of actin dynamics is VASP, and phosphorylation of VASP rapidly mediates platelet shape changes. 29 Vasodilator-stimulated phosphoprotein contains 3 possible phosphorylation sites (Ser 157 , Ser 239 , and Thr 278 ), and 2 of these are described as important determinants of platelet function (Ser 157 and Ser 239 ). We therefore proceeded to selectively phosphorylate the VASP Ser 157 site (through PGE 1 ) and the VASP Ser 239 site (through ANP) to pursue the role of this on PNC formation and transendothelial PNC movement ( Figure 1C ). After preincubation with PGE 1 or ANP, we found a significant reduction of cell number and ATP concentration within the basolateral compartment ( Figure 1D and 1E) . As a consequence of transendothelial movement, large PNC complexes were present in the basolateral compartment in control experiments but not after preincubation of neutrophils and platelets with PGE 1 or ANP ( Figure 1F and online-only Data Supplement Figure III ).
Next, we investigated whether GP IIb/IIIa expression and activation, as well as CD11b expression, would be affected by PGE 1 or ANP treatment. Prostaglandin E 1 or ANP treatment had no influence on the global expression of the GP IIb/IIIa complex on platelets. However, the induction of the high-affinity binding state of GP IIb/IIIa was significantly reduced after incubation with PGE 1 or ANP. We did not observe alterations of CD11b expression on the surface of neutrophils by PGE 1 or ANP treatment ( Figure 1G 
Vasodilator-Stimulated Phosphoprotein ؊/؊ Mice Demonstrate Reduced Platelet-Neutrophil Complexes Formation and Attenuated Myocardial IR Injury
We then proceeded to investigate whether this finding could have in vivo significance and used a model myocardial IR injury for this. Initially, we determined whether VASP Ϫ/Ϫ animals would demonstrate altered characteristics of receptor expression. We determined the expression of GP IIb/IIIa and P-selectin, but did not find a difference between WT or VASP Ϫ/Ϫ animals (online-only Data Supplement Figure  V) . We then exposed VASP Ϫ/Ϫ mice and littermate controls to 60 minutes of myocardial ischemia followed by 3 hours of reperfusion. VASP-deficient mice demonstrated a significant reduction of myocardial infarct size compared with controls; this was corroborated through serum troponin I levels (Figure 2A through 2C) . Furthermore, 5 minutes after the initiation of reperfusion, the number of PNCs in whole blood samples was significantly lower in VASP Ϫ/Ϫ animals compared with WT controls ( Figure  2D ). At the end of the reperfusion period, we obtained tissue sections of the affected myocardium and examined these sections for the presence of PNCs. We found a reduced presence of PNCs within tissue of VASP Ϫ/Ϫ animals compared with littermate controls (Figure 2E and 2F).
To gain further insight into the specific role of VASP, we used gene-targeted repression using siRNA and injected animals 24 hours before the start of the experiment with siVASP or control siRNA. This resulted in significant VASP repression in vivo (online-only Data Supplement Figure VI) . We then proceeded to subject these animals to the myocardial IR model and found reduced myocardial tissue damage in the siVASP treated animals compared to siRNA controls. This was associated with a reduced presence of PNCs within the affected myocardial tissue (online-only Data Supplement Figure VII ).
Platelet Depletion, Neutrophil Depletion, and Crossover Injection Identify the Importance of Platelet-Neutrophil Complexes for Myocardial Ischemia-Reperfusion Injury
To gain further insight whether the observed protective effect of VASP depletion is indeed mediated through PNCs, we selectively depleted platelets before animals were exposed the model of myocardial IR injury. Platelet depletion resulted in a significant reduction of myocardial IR injury infarct size in WT and in VASP Ϫ/Ϫ animals. Wild-type animals demonstrated an infarct size of 4.5Ϯ2.4%, VASP Ϫ/Ϫ animals of 3.5Ϯ1.4% ( Figure 3A through 3C) . When examining tissue sections after myocardial IR injury, we did not find PNCs within the tissue sections of WT or VASP Ϫ/Ϫ animals ( Figure  3D and 3E) . Depletion of neutrophils resulted in a similar finding: Myocardial infarct size was significantly reduced in WT animals (5.4Ϯ1.4%) and in VASP Ϫ/Ϫ animals (5.3Ϯ1.3%) ( Figure 3F through 3H) . Platelet-neutrophil complexes were not present within myocardial tissue, corroborat-ing the importance of PNC formation for myocardial IR injury.
Next, we asked whether PNC formation and myocardial IR injury would be influenced by VASP expression of platelets. We separated platelets from WT or VASP Ϫ/Ϫ animals and performed crossover injection of these platelets preceding IR injury. The separation process we used did not result in an activation of the extracted platelets, and separated platelets were still functionally sound (onlineonly Data Supplement Figure VIII) . We then transferred VASP Ϫ/Ϫ platelets into WT animals before the start of myocardial ischemia and found that this resulted in a reduction of myocardial IR injury of Ϸ40% compared with WT-to-WT injected animals ( Figure 4A of myocardial tissue damage was reflected in serum troponin I levels ( Figure 4B ). When determining the PNC count within tissue sections, we found a reduced presence of PNCs within tissue of WT animals receiving VASP Ϫ/Ϫ platelets and an increased presence of PNCs in VASP Ϫ/Ϫ animals injected with WT platelets within the myocardial tissue ( Figure 4E ).
Platelet-Neutrophil Complexes Formation Is Dependent on Hematopoietic Vasodilator-Stimulated Phosphoprotein Expression
To further clarify the role of VASP in myocardial IR injury and the formation of PNCs, we generated chimeric animals using bone marrow transplantation (online-only Data Supplement Figure IX) . Six weeks after bone marrow transplantation, we performed the above-described myocardial IR model. In chimeric animals, myocardial IR injury was dependent on hematopoietic VASP expression, demonstrating reduced myocardial damage in the VASP Ϫ/Ϫ 3 WT transplanted animals. The control transplanted animals (WT3 WT and VASP Ϫ/Ϫ 3VASP Ϫ/Ϫ ) reflected the results of the WT or VASP Ϫ/Ϫ animals ( Figure 5A through 5C ). We then determined the presence of PNCs within the blood 5 minutes after the initiation of reperfusion and found that the WT3VASP Ϫ/Ϫ transplanted animals demonstrated a similar number of PNCs within the blood as the WT3 WT transplanted animals did. In the VASP Ϫ/Ϫ 3 WT transplanted animals, we found a significantly reduced number of PNCs within the blood compared to the WT3VASP Ϫ/Ϫ transplanted animals ( Figure 5D ). When examining myocardial tissue sections for the presence of PNCs, we found that VASP Ϫ/Ϫ 3 WT transplanted animals showed a reduced presence of PNCs compared with the WT3VASP Ϫ/Ϫ transplanted animals. This was associated with a decrease in myocardial tissue destruction ( Figure 5E and 5F) . 
Vasodilator-Stimulated Phosphoprotein Phosphorylation Reduces In Vivo Platelet-Neutrophil Complexes Formation and Myocardial IR Injury
We were able to demonstrate the in vitro relevance of VASP phosphorylation for PNC formation and transendothelial movement of PNCs. It has been reported that in vivo VASP phosphorylation correlates with a reduced platelet activation state. We therefore next pursued the role of VASP phosphorylation in vivo for the formation of PNCs, inducing selective VASP phosphorylation with PGE 1 or ANP ( Figure 6A ). First, we investigated potential hemodynamic changes after PGE 1 or ANP injection but did not find a significant influence of these agents on hemodynamic values (online-only Data Supplement Figure X) . Prostaglandin E 1 infusion reduced the extent of myocardial tissue damage in the WT animals, yet we did not observe this effect in the VASP Ϫ/Ϫ animals. When using ANP to induce VASP Ser 235 phosphorylation, we also found a significant reduction of myocardial tissue injury in the WT animals, yet this was not present in VASP Ϫ/Ϫ animals ( Figure 6B and 6D) . Troponin I measurements confirmed these ( Figure 6C ). When examining the presence of circulating PNCs in the blood of these mice, we found that the infusion of PGE 1 or ANP resulted in a significant reduction of PNCs in the blood of WT but not of VASP Ϫ/Ϫ animals ( Figure  6E ). We then proceeded to identify the potential presence of PNCs in myocardial tissue and found that WT animals treated with PGE 1 or ANP demonstrated a reduced number of PNCs in myocardial tissue compared with controls. Plateletneutrophil complexes were not reduced in VASP Ϫ/Ϫ animals after PGE 1 or ANP exposure ( Figure 6F and 6G ).
Phosphorylation of Hematopoietic Vasodilator-Stimulated Phosphoprotein Reduces Platelet-Neutrophil Complexes Formation and Myocardial Ischemia-Reperfusion Injury
Our previous experiments have demonstrated that hematopoietic-derived VASP expression is of crucial importance for formation of PNCs during myocardial IR injury. To provide more evidence for this, we continued to test the role of VASP phosphorylation in chimeric animals. For this purpose, we employed PGE 1 or ANP in VASP Ϫ/Ϫ 3 WT and WT3VASP Ϫ/Ϫ transplanted animals. Evaluation of the infarct size revealed that PGE 1 significantly reduced myocardial tissue damage in the WT3VASP Ϫ/Ϫ transplanted animals but had no effect in the VASP Ϫ/Ϫ 3 WT transplanted animals. Similarly, ANP resulted in a significant reduction of myocardial tissue damage through VASP phosphorylation in the WT3VASP Ϫ/Ϫ transplanted animals, but had no effect in the WT3VASP Ϫ/Ϫ transplanted animals. Troponin I measurement confirmed this finding ( Figure 7A through 7C) . When examining the presence of PNCs within the blood of these animals, we found that WT3VASP Ϫ/Ϫ transplanted animals demonstrated a significant reduction of PNCs within the blood after infusion of PGE 1 or ANP. This was however not observed in the VASP Ϫ/Ϫ 3 WT transplanted animals ( Figure 7D ). We then proceeded to identify the presence of PNCs within ischemic myocardial tissue of these animals. In tissue sections we found a reduced presence of PNCs in the WT3VASP Ϫ/Ϫ transplanted animals after PGE 1 or ANP infusion, confirming the role of hematopoietic VASP for the formation of PNCs ( Figure 7E and 7F ).
Discussion
Recent work has appreciated the importance of PNC formation during acute lung injury and has demonstrated that neutrophils facilitate the transepithelial movement of platelets. 9, 10 The role of PNCs during IR injury to date is however not known. We demonstrate here that the formation of PNCs has a significant impact on the extent of myocardial IR injury and that phosphorylation of the cytoskeletal protein VASP affects the formation of PNCs. In initial in vitro studies, we found that neutrophils facilitate the movement of platelets across an endothelial monolayer and that this process can be attenuated through phosphorylation of VASP. Studies employing VASP Ϫ/Ϫ and chimeric animals revealed that hematopoetic VASP significantly influences the formation of PNCs in vivo. Furthermore, VASP phosphorylation dampened the intravascular formation during reperfusion and the movement of PNCs into ischemic myocardial tissue and for this reason significantly reduced myocardial IR injury. Therefore, these studies define the role of PNCs for myocardial tissue injury and identify VASP as a key regulator of PNC formation. The formation of PNCs is achieved through fibrinogen bridging between the GP IIb/IIIa receptor on platelets and CD11b/CD18 on neutrophils. 30 In in vitro studies we found that the expression of GP IIb/IIIa on platelets is altered through the phosphorylation of VASP on Ser 157 and Ser 239 . We used ANP to selectively induce phosphorylation of VASP at Ser 239 31 and PGE 1 to induce VASP phosphorylation at Ser 157 . 32 This resulted in a reduction of PNC formation in vitro and in vivo. This finding is supported by a study from Scotland et al in which platelet-leukocyte interactions and PNC formation were reduced through C-type natriuretic peptide. C-type natriuretic peptide increases intracellular cGMP with a subsequent phosphorylation of VASP on Ser 239 . 33 This reduction of PNC formation was accompanied by a reduced expression of P-selectin on the platelet surface. 34 An increase of intracellular cGMP within platelets is also achieved through nitric oxide, which is a well-defined inhibitor of platelet activation and P-selectin expression. The cAMP-dependent phosphorylation of VASP at Ser 157 reduces the affinity of the platelet fibrinogen receptor to bind fibrinogen and collagen. 28 In partial contrast to this is a study by Massberg et al in which the authors demonstrate an increased tethering of VASP Ϫ/Ϫ platelets on the vascular wall. The authors concluded that the loss of VASP increased loose platelet adhesion that was dependent on P-selectin expression and that following denudation of the vascular wall increased adhesion of VASP Ϫ/Ϫ platelets was dependent on the platelet GP IIb/IIIa receptor. 35 But the authors also point out that VASP expression within the vascular wall is essential to control platelet-endothelial interactions. The primary focus of our study however was not on the tethering of platelets on the vascular wall but rather on the firm linkage between neutrophils and platelets for PNC formation. Therefore, given the previously discussed literature, the finding that VASP phosphorylation through ANP or PGE 1 alters PNC formation might well explain the reduction of PNC formation. This would at least in part provide further explanation to the clinically observed protective role of ANP and PGE 1 during myocardial IR injury. 36, 37 The functional importance of PNC formation for the extent of inflammatory tissue injury has been implicated previously. Kupatt et al demonstrated that a reduction of PNC formation through c7E3Fab, a chimeric Fab fragment blocking the GP IIb/IIIa receptor resulted in improved postischemic recovery of the external heart work. 38 The importance of the formation of PNCs for the extent of inflammatory tissue damage has been recognized in a recent study by Zarbock et al examining the role of the PNCs during acute lung injury. 9 Zarbock et al demonstrated that acid-induced lung injury is aggravated by the formation of PNCs. The inhibition of this PNC formation resulted in a marked decrease in pulmonary injury and improved pulmonary function. A subsequent study by Loo- Figure 6 . Phosphorylation of VASP dampens PNC formation and attenuates myocardial IR injury. A, Western blots from whole blood samples from WT mice after injection with either PGE 1 or ANP, showing VASP phosphorylation at murine VASP Ser 153 by PGE 1 and at murine VASP Ser 235 by ANP. B, Infarct size of WT and VASP Ϫ/Ϫ animals after 60 minutes of myocardial ischemia followed by 2 hours reperfusion with infusion of vehicle, PGE 1 , or ANP during reperfusion. Shown is the percentage of necrotic tissue in the AAR and (C) correlating troponin I values. D, Representative images of myocardial infarcts (blue/darkϭretrograde Evan blue staining; red and whiteϭAAR; whiteϭinfarcted tissue). E, Number of PNCs detected in whole blood 5 minutes after the initiation of reperfusion in VASP Ϫ/Ϫ or WT mice with PGE 1 or ANP infusion. F, Histological images of PNCs (neutrophilsϭblue; plateletsϭblack) in tissue sections of myocardial infarcts of all groups. G, Number of PNCs present in histological sections of VASP Ϫ/Ϫ or WT mice with PGE 1 or ANP infusion (data are shown as meanϮSEM; nϭ6; ***PϽ0.001 as indicated; tissue sections magnification ϫ400; insert ϫ1000; nϭ3; 1 representative of 3 individual experiments is demonstrated). VASP indicates vasodilator-stimulated phosphoprotein; con, control; ANP, atrial natriuretic peptide; PGE 1 , prostaglandin E 1 ; and PNCs, platelet-neutrophil complexes. ney et al corroborated this by demonstrating that platelet depletion or aspirin pretreatment resulted in reduced transfusion-related lung injury. In this study, the interaction of neutrophils with platelets was not dependent on P-selectin expression. 39 Weissmüller et al demonstrated that after formation PNCs are translocated across an epithelial cell barrier. The translocated platelets subsequently released ATP, which induces the function of ectonucleotidases in the intestinal lumen. 10, 40 This demonstrates that translocation of PNCs across a cellular layer is possible and that the translocated platelets are functionally intact. In line with these previous studies, we demonstrate here that neutrophils facilitate the transendothelial movement of platelets forming PNCs in vitro and that this PNC formation and movement is also present in vivo. Furthermore, we demonstrate that neutrophils-facilitated platelet movement can be reduced through the phosphorylation of VASP, which has a significant impact on myocardial IR injury. This finding correlates well with the clinical strategy to reduced platelet activation during the reperfusion phase. 41 The selective depletion of platelets or neutrophils we used here demonstrates that the formation of PNCs is of crucial importance for the extent of myocardial IR injury.
In summary, the results of our study are in line with previous investigations demonstrating the importance of PNCs for the extent of inflammatory tissue injury and confirm that the reduction of PNC formation might be tissue protective. The regulatory role of VASP phosphorylation for the formation of PNC was identified in vitro and transferred into in vivo evidence. Vasodilator-stimulated phosphoprotein phosphorylation resulted in reduced formation of PNC and dampened the extent of myocardial IR injury. This work therefore increases our understanding of the mechanisms underlying the formation of PNCs, supports the importance of PNCs for the extent of IR injury, and increases our understanding of the role of VASP during myocardial IR injury.
